awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42420437-A5175B7D-8B41-4978-8E14-1BC2A1EF4FC1
Q42420437-A5175B7D-8B41-4978-8E14-1BC2A1EF4FC1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42420437-A5175B7D-8B41-4978-8E14-1BC2A1EF4FC1
Sustained intraocular pressure elevation after intravitreal injection of bevacizumab and ranibizumab associated with trabeculitis.
P2860
Q42420437-A5175B7D-8B41-4978-8E14-1BC2A1EF4FC1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42420437-A5175B7D-8B41-4978-8E14-1BC2A1EF4FC1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9d05af31ee877940f94e42fcc1773ac1f0f2a19b
P2860
Comparative study of intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) in the treatment of neovascular age-related macular degeneration.